BRIEF published on 05/31/2024 at 17:03, 1 year 6 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA FDA Approval Moderna Vaccine RSV MRESVIA
BRIEF published on 05/31/2024 at 17:03, 1 year 6 months ago Moderna reçoit l'approbation de la FDA américaine pour le vaccin contre le RSV mRESVIA Approbation De La FDA Moderne VRS MRESVIA Vaccin
PRESS RELEASE published on 05/31/2024 at 16:58, 1 year 6 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) Moderna gains FDA approval for mRESVIA, a single-dose pre-filled syringe RSV vaccine for adults 60+ to prevent lower respiratory tract disease. Second mRNA product and breakthrough therapy designation FDA Approval Moderna RSV Vaccine MRNA MRESVIA
BRIEF published on 05/22/2024 at 13:05, 1 year 6 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Clinical Trials Immunotherapy Moderna ASCO 2024 MRNA-4157
BRIEF published on 05/22/2024 at 13:05, 1 year 6 months ago Moderna annonce que les données seront présentées lors de l'assemblée annuelle 2024 de l'ASCO Immunothérapie Essais Cliniques Moderne ASCO 2024 ARNm-4157
PRESS RELEASE published on 05/22/2024 at 13:00, 1 year 6 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Moderna to host an investor event via webcast on June 3 at 6:15 PM CDT. Abstracts on mRNA-4157 for ASCO Annual Meeting. Details on mRNA-4157 (V940) therapy development Webcast Moderna Investor Event MRNA-4157 Neoantigen Therapy
BRIEF published on 05/13/2024 at 13:05, 1 year 7 months ago Moderna Announces Participation in Key Investor Conferences Investor Conferences Healthcare Financial Markets Moderna Webcasts
BRIEF published on 05/13/2024 at 13:05, 1 year 7 months ago Moderna annonce sa participation à des conférences clés pour les investisseurs Marchés Financiers Soins De Santé Conférences Investisseurs Moderne Webdiffusions
PRESS RELEASE published on 05/13/2024 at 13:00, 1 year 7 months ago Moderna to Present at Upcoming Conferences in May/June 2024 Moderna, Inc. to participate in upcoming investor conferences, showcasing its leadership in mRNA medicine and innovative approach to disease treatment. Live webcasts available Investor Conferences Moderna Inc. MRNA Medicine Webcasts Disease Treatment
BRIEF published on 05/02/2024 at 12:35, 1 year 7 months ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
Published on 12/20/2025 at 00:30, 1 day 20 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 22 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 2 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 5 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 7 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/21/2025 at 08:55, 11 hours 38 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 3 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 10 hours ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 22 hours ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 1 day 22 hours ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 21:57, 1 day 22 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 12 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 12 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 13 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 13 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
